![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 3
2025
Sarkozy, Clémentine; Chartier, Loïc; Ribrag, Vincent; Gressin, Remy 
ORCID: https://orcid.org/0000-0002-9188-3501; Geisler, Christian H.; Kluin-Nelemans, Hanneke C.; Thieblemont, Catherine ORCID: https://orcid.org/0000-0002-9941-2448; Morschhauser, Franck ORCID: https://orcid.org/0000-0002-3714-9824; Lemonnier, François ORCID: https://orcid.org/0000-0001-6205-5419; Safar, Violaine; Tessoulin, Benoît ORCID: https://orcid.org/0000-0001-7600-3329; Oberic, Lucie; Damaj, Ghandi ORCID: https://orcid.org/0000-0002-4689-3882; Ghesquières, Hervé; Bouabdallah, Krimo; Casasnovas, René Olivier ORCID: https://orcid.org/0000-0002-1156-8983; Houot, Roch; Klapper, Wolfram ORCID: https://orcid.org/0000-0001-7208-4117; Burroni, Barbara; Pott, Christiane ORCID: https://orcid.org/0009-0005-9260-8340; Delfau-Larue, Marie-Hélène; Macintyre, Elizabeth ORCID: https://orcid.org/0000-0003-0520-0493; Callanan, Mary; Jerkeman, Mats; Unterhalt, Michael; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249; Le Gouill, Steven; Hermine, Olivier und Cheminant, Morgane ORCID: https://orcid.org/0000-0002-2070-9581
(2025):
Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study.
In: Blood Cancer Journal, Bd. 15, 78
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-9188-3501; Geisler, Christian H.; Kluin-Nelemans, Hanneke C.; Thieblemont, Catherine ORCID: https://orcid.org/0000-0002-9941-2448; Morschhauser, Franck ORCID: https://orcid.org/0000-0002-3714-9824; Lemonnier, François ORCID: https://orcid.org/0000-0001-6205-5419; Safar, Violaine; Tessoulin, Benoît ORCID: https://orcid.org/0000-0001-7600-3329; Oberic, Lucie; Damaj, Ghandi ORCID: https://orcid.org/0000-0002-4689-3882; Ghesquières, Hervé; Bouabdallah, Krimo; Casasnovas, René Olivier ORCID: https://orcid.org/0000-0002-1156-8983; Houot, Roch; Klapper, Wolfram ORCID: https://orcid.org/0000-0001-7208-4117; Burroni, Barbara; Pott, Christiane ORCID: https://orcid.org/0009-0005-9260-8340; Delfau-Larue, Marie-Hélène; Macintyre, Elizabeth ORCID: https://orcid.org/0000-0003-0520-0493; Callanan, Mary; Jerkeman, Mats; Unterhalt, Michael; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249; Le Gouill, Steven; Hermine, Olivier und Cheminant, Morgane ORCID: https://orcid.org/0000-0002-2070-9581
(2025):
Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study.
In: Blood Cancer Journal, Bd. 15, 78
[PDF, 1MB]
2022
Shah, Bijal D.; Ghobadi, Armin; Oluwole, Olalekan O.; Logan, Aaron C.; Boissel, Nicolas; Cassaday, Ryan D.; Leguay, Thibaut; Bishop, Michael R.; Topp, Max S.; Tzachanis, Dimitrios; O'Dwyer, Kristen M.; Arellano, Martha L.; Lin, Yi; Baer, Maria R.; Schiller, Gary J.; Park, Jae H.; Subklewe, Marion; Abedi, Mehrdad; Minnema, Monique C.; Wierda, William G.; DeAngelo, Daniel J.; Stiff, Patrick; Jeyakumar, Deepa; Dong, Jinghui; Adhikary, Sabina; Zhou, Lang; Schuberth, Petra C.; Faghmous, Imi; Masouleh, Behzad Kharabi und Houot, Roch
(2022):
Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study.
In: Journal of Hematology & Oncology, Bd. 15, Nr. 1, 170
2021
Shah, Bijal D.; Ghobadi, Armin; Oluwole, Olalekan O.; Logan, Aaron C.; Boissel, Nicolas; Cassaday, Ryan D.; Leguay, Thibaut; Bishop, Michael R.; Topp, Max S.; Tzachanis, Dimitrios; O'Dwyer, Kristen M.; Arellano, Martha L.; Lin, Yi; Baer, Maria R.; Schiller, Gary J.; Park, Jae H.; Subklewe, Marion; Abedi, Mehrdad; Minnema, Monique C.; Wierda, William G.; DeAngelo, Daniel J.; Stiff, Patrick; Jeyakumar, Deepa; Feng, Chaoling; Dong, Jinghui; Shen, Tong; Milletti, Francesca; Rossi, John M.; Vezan, Remus; Masouleh, Behzad Kharabi und Houot, Roch
(2021):
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study.
In: Lancet, Bd. 398, Nr. 10299: S. 491-502